DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer's Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation

Author： Lambracht-Washington Doris  

Publisher： Springer Publishing Company

ISSN： 0272-4340

Source： Cellular and Molecular Neurobiology, Vol.31, Iss.6, 2011-08, pp. : 867-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer's Disease

By Oh Esther  

NeuroMolecular Medicine, Vol. 10, Iss. 3, 2008-09 ,pp. : 195-207

Humana Press, Inc

Access to resources Recommend Favorite

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

By Donahue John   Flaherty Stephanie   Johanson Conrad   Duncan John   Silverberg Gerald   Miller Miles   Tavares Rosemarie   Yang Wentian   Wu Qian   Sabo Edmond   Hovanesian Virginia   Stopa Edward  

Acta Neuropathologica, Vol. 112, Iss. 4, 2006-10 ,pp. : 405-415

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer's Disease: From Acetylcholine to beta-Amyloid

By Palmer A.M.   Francis P.T.  

Neurodegeneration, Vol. 5, Iss. 4, 1996-12 ,pp. : 379-380

Academic Press

Access to resources Recommend Favorite

Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer's Disease

By Sambamurti K.   Greig N.H.   Lahiri D.K.  

NeuroMolecular Medicine, Vol. 1, Iss. 1, 2002-03 ,pp. : 2-32

Humana Press, Inc

Access to resources Recommend Favorite

Amyloid Beta Protein as a Marker or Risk Factor of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 4, 2007-01 ,pp. : 359-363

Bentham Science Publishers

Access to resources Recommend Favorite